Model
Edge
CRISPR Therapeutics
0001968317
Filing Type
4
Filing Date
10/16/2023
Updated
10/17/23, 11:52 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership